Alseres Pharmaceuticals (Alseres Pharmaceuticals) FCF Margin % : -1,511.11% (As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is Alseres Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alseres Pharmaceuticals's Free Cash Flow for the three months ended in Jun. 2014 was $-0.27 Mil. Alseres Pharmaceuticals's Revenue for the three months ended in Jun. 2014 was $0.02 Mil. Therefore, Alseres Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2014 was -1,511.11%.

As of today, Alseres Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Alseres Pharmaceuticals's FCF Margin % or its related term are showing as below:

ALSE' s FCF Margin % Range Over the Past 10 Years
Min: -284.75 Med: 0 Max: 0
Current: -284.75

ALSE's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -149.8 vs ALSE: -284.75

Alseres Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Alseres Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alseres Pharmaceuticals FCF Margin % Chart

Alseres Pharmaceuticals Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

FCF Margin %

Get a 7-Day Free Trial

-179.28

-355.91

Alseres Pharmaceuticals Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
FCF Margin %	Get a 7-Day Free Trial															-1,666.67	-1,672.22	-92.34	-2,138.89	-1,511.11

Competitive Comparison of Alseres Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Alseres Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alseres Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alseres Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alseres Pharmaceuticals's FCF Margin % falls into.

Alseres Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alseres Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2013 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2013 )	/	Revenue (A: Dec. 2013 )
	=	-1.687	/	0.474
	=	-355.91 %

Alseres Pharmaceuticals's FCF Margin for the quarter that ended in Jun. 2014 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2014 )	/	Revenue (Q: Jun. 2014 )
	=	-0.272	/	0.018
	=	-1,511.11 %

Alseres Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alseres Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alseres Pharmaceuticals Inc (OTCPK:ALSE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

275 Grove Street, Suite 2-400, Auburndale, MA, USA, 02466

Website

http://www.alseres.com

Alseres Pharmaceuticals Inc is a US-based biotechnology company. It is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. The company's lead product candidate is Altropane, a proprietary molecular imaging agent which is used to diagnose Parkinson's disease and dementia. Further, it is focused on entering into partnerships to ensure development and commercialization of its product. Geographically the firm carries out its business through the region of United States.

Executives

Mark Jerome Pykett	officer: President and COO	223A MAIN ST, BOXFORD MA 021921
Robert Langer	director	98 MONTVALE RD, NEWTON MA 02459
Peter G Savas	director, officer: Chief Executive Officer	110 HARTWELL AVENUE, LEXINGTON MA 02173
John T Preston	director	C/O MOLTEN METAL TECHNOLOTY INC, 400-2 TOTTEN POND ROAD, WALTHAM MA 02154
Rice Kenneth L Jr	officer: Exec VP of Fin & Admin & CFO	C/O 85 MAIN STREET, HOPKINTON MA 01748
Joseph P Hernon	officer: Chief Financial Officer	1607 PONCE DE LEON AVENUE, SUITE 407, SAN JUAN PR 00909
Stephen M Peck	director	P O BOX 554, 3600 S LAKE DRIVE, ST FRANCIS WI, MILWAUKEE WI 53201-0554

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Headlines

From GuruFocus

Alseres Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus • 05-15-2009

Alseres Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-16-2009

Alseres Pharmaceuticals Inc. Reports Operating Results (10-Q)

By gurufocus • 08-14-2009